We are looking to hire a postdoctoral fellow holding a PhD in Bioinformatics or Genetics/Epigenetics with strong expertise in next-generation sequencing (NGS) data analysis to lead the bioinformatic component of our research program. That person will be proficient in C++, Java, Python, R and unix environments, including supercomputing applications. Optimally, the recruited person will also have expertise in conducting statistical analyses and algorithm development. The individual needs to be independent and motivated to perform genomic, epigenomic and transcriptomic analyses — the primary mentor will be Dr. Belzil and a bioinformatics professor will be available for guidance.
Dr. Belzil is an Assistant Professor in the Department of Neuroscience at Mayo Clinic College of Medicine and an Associate Consultant for the Mayo Clinic Center for Individualized Medicine in Jacksonville, Florida. She is also an Adjunct Professor in the Department of Neurology and Neurosurgery at the Montreal Neurological Institute of McGill University.
Her laboratory aims to identify genomic/epigenomic/transcriptomic mediators of neurodegeneration and evaluate their potential as biomarkers and therapeutic targets for amyotrophic lateral sclerosis (ALS) and other related diseases. Specifically, using state-of-the-art integrative multi-omics bioinformatic and system biology approaches, her laboratory aims to (1) better understand genome-epigenome-transcriptome interactions leading to ALS; (2) develop clinically relevant and scalable ALS-specific biomarker panels to guide more tailored management of ALS patients; (3) inform the next generation of individualized clinical trials for ALS; (4) identify key pathological pathways and genetic & epigenetic modifiers of transcription mediating neurodegeneration susceptibility that can be targeted by therapeutics; (5) generate results that can quickly be translated from bench to bedside: we want to quickly impact clinical practice and promote individualized medicine and (6) promote collaborative efforts — collaborations and team work is essential to finding a cure for ALS.
Please do not hesitate to contact us with any questions you may have about this opportunity.
Veronique Belzil, PhD